Bridgeway Capital Management’s Repligen RGEN Stock Holding History

Bridgeway Capital Management’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-8,560	Closed	-$1.61M	–	1377
2022 Q1	$1.61M	Hold	8,560	–	–	0.03%	663
2021 Q4	$2.27M	Sell	8,560 -10,300	-55%	-$2.77M	0.04%	570
2021 Q3	$5.45M	Sell	18,860 -5,190	-22%	-$1.33M	0.1%	297
2021 Q2	$4.8M	Sell	24,050 -150	-0.6%	-$29.1K	0.09%	325
2021 Q1	$4.71M	Buy	24,200 +10,300	+74%	+$2.11M	0.09%	306
2020 Q4	$2.66M	Hold	13,900	–	–	0.06%	417
2020 Q3	$2.05M	Buy	+13,900	New	+$1.99M	0.05%	419
2015 Q4	–	Sell	-30,000	Closed	-$836K	–	1488
2015 Q3	$836K	Hold	30,000	–	–	0.02%	813
2015 Q2	$1.24M	Hold	30,000	–	–	0.02%	702
2015 Q1	$911K	Sell	30,000 -20,350	-40%	-$528K	0.02%	819
2014 Q4	$997K	Sell	50,350 -8,550	-15%	-$191K	0.02%	769
2014 Q3	$1.17M	Sell	58,900 -25,700	-30%	-$541K	0.03%	697
2014 Q2	$1.93M	Sell	84,600 -1,000	-1%	-$17.8K	0.05%	523
2014 Q1	$1.1M	Sell	85,600 -38,500	-31%	-$552K	0.03%	718
2013 Q4	$1.69M	Hold	124,100	–	–	0.05%	552
2013 Q3	$1.38M	Hold	124,100	–	–	0.05%	582
2013 Q2	$1.02M	Buy	+124,100	New	+$1.04M	0.04%	621

Other funds holding RGEN

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Bridgeway Capital Management's RGEN Position: Q2 2022 in Review

Bridgeway Capital Management sold out of Repligen (RGEN) in Q2 2022, closing a stake of 8,560 shares — an estimated $1.61M sold.

Bridgeway Capital Management first reported a position in RGEN in Q2 2013 and held it in 17 quarters. The position peaked at $5.45M in Q3 2021. 405 funds tracked by Wall St. Rank hold RGEN as of Q2 2022.

Bridgeway Capital Management reported no remaining Repligen position as of Q2 2022 after selling out during the quarter.
Bridgeway Capital Management sold 8,560 Repligen shares in Q2 2022, an estimated $1.61M.
Bridgeway Capital Management first reported a position in Repligen in Q2 2013 and held it in 17 quarters.
Bridgeway Capital Management's Repligen position peaked at $5.45M in Q3 2021.
405 funds tracked by Wall St. Rank held Repligen as of Q2 2022.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.